These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31450767)

  • 1. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma.
    Papoutsoglou P; Louis C; Coulouarn C
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
    Zhang BY; Zhang JY; Zhao K; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma.
    Papoutsoglou P; Pineau R; Leroux R; Louis C; L'Haridon A; Foretek D; Morillon A; Banales JM; Gilot D; Aubry M; Coulouarn C
    EMBO Rep; 2024 Mar; 25(3):1022-1054. PubMed ID: 38332153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of transforming growth factor-beta signaling in pancreatic cancer.
    Lin X; Feng XH
    World J Surg; 2005 Mar; 29(3):312-6. PubMed ID: 15706432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.
    Sugimachi K; Nishio M; Aishima S; Kuroda Y; Iguchi T; Komatsu H; Hirata H; Sakimura S; Eguchi H; Bekki Y; Takenaka K; Maehara Y; Suzuki A; Mimori K
    Oncology; 2017; 93(1):67-74. PubMed ID: 28448997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
    Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic roles of TGFβ/Smad signaling in the progression of chronic liver disease.
    Xu L; Tian D; Zheng Y
    Crit Rev Eukaryot Gene Expr; 2013; 23(3):237-55. PubMed ID: 23879540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Desille M; Turlin B; Fautrel A; Boucher E; Llamas-Gutierrez F; Meunier B; Boudjema K; Clément B; Coulouarn C
    Hepatology; 2013 Dec; 58(6):1992-2000. PubMed ID: 23775819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.
    Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R
    Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β signaling in liver and gastrointestinal cancers.
    Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
    Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
    Lee KT; Liu TS
    World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
    Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TGFbeta signaling for cancer therapy.
    Iyer S; Wang ZG; Akhtari M; Zhao W; Seth P
    Cancer Biol Ther; 2005 Mar; 4(3):261-6. PubMed ID: 15846079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma.
    Merdrignac A; Angenard G; Allain C; Petitjean K; Bergeat D; Bellaud P; Fautrel A; Turlin B; Clément B; Dooley S; Sulpice L; Boudjema K; Coulouarn C
    Hepatol Commun; 2018 Mar; 2(3):254-269. PubMed ID: 29507901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.